| scholarly article | Q13442814 |
| P50 | author | Thirumalaisamy P. Velavan | Q58385309 |
| Albert Lalremruata | Q64629946 | ||
| Andrea Kreidenweiss | Q79436227 | ||
| Jean Claude Dejon Agobe | Q87571004 | ||
| Bayodé Roméo Adegbite | Q90774692 | ||
| Ghyslain Mombo-Ngoma | Q91380889 | ||
| Ayola A. Adegnika | Q92016826 | ||
| Peter Gottfried Kremsner | Q50345544 | ||
| P2093 | author name string | Benjamin Mordmüller | |
| Bertrand Lell | |||
| Selidji T Agnandji | |||
| Michael Ramharter | |||
| Erik Koehne | |||
| Jean R Edoa | |||
| Yabo J Honkpehedji | |||
| Frejus J Zinsou | |||
| Abdou R Safiou | |||
| Bayode R Adegbite | |||
| Fabrice Lotola-Mougueni | |||
| Fridia A Obone Atome | |||
| Jutta Kun | |||
| Mirabeau Mbong-Ngwese | |||
| The T Nguyen | |||
| P2860 | cites work | Artemisinin Resistance in Plasmodium falciparum Malaria | Q22061852 |
| Evidence of Artemisinin-Resistant Malaria in Western Cambodia | Q22061854 | ||
| A molecular marker of artemisinin-resistant Plasmodium falciparum malaria | Q22061872 | ||
| An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria | Q28473004 | ||
| A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial | Q28477853 | ||
| Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial | Q28552379 | ||
| A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms. | Q30379780 | ||
| Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017. | Q52609473 | ||
| Efficacy and tolerability of artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria at two sentinel sites across Côte d’Ivore | Q56417882 | ||
| Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy | Q33576812 | ||
| The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study | Q33607319 | ||
| Molecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria | Q33721915 | ||
| Open-label, randomized, non-inferiority clinical trial of artesunate-amodiaquine versus artemether-lumefantrine fixed-dose combinations in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire | Q34611124 | ||
| High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children | Q35038632 | ||
| Monitoring the efficacy and safety of three artemisinin based-combinations therapies in Senegal: results from two years surveillance | Q35071899 | ||
| A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon | Q35549781 | ||
| Artesunate--amodiaquine combination therapy for falciparum malaria in young Gabonese children | Q35695222 | ||
| Efficacy and Safety of Artesunate-Amodiaquine versus Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium falciparum Malaria in Sentinel Sites across Côte d'Ivoire | Q35996318 | ||
| Prospective evaluation of artemether-lumefantrine for the treatment of non-falciparum and mixed-species malaria in Gabon | Q36086864 | ||
| Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana | Q36212917 | ||
| Demography, maternal health and the epidemiology of malaria and other major infectious diseases in the rural department Tsamba-Magotsi, Ngounie Province, in central African Gabon | Q36262884 | ||
| Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations in the treatment of uncomplicated malaria in two ecological zones in Ghana | Q36428340 | ||
| In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays | Q37184295 | ||
| Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children. | Q37188820 | ||
| Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial | Q37270727 | ||
| Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria from three highly malarious states in India | Q37340772 | ||
| Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015. | Q37623024 | ||
| Efficacy of Artesunate/Amodiaquine in the Treatment of Uncomplicated Malaria among Children in Ghana | Q38657672 | ||
| Polymorphisms in the parasite genes for pfcrt and pfmdr-1 as molecular markers for chloroquine resistance in Plasmodium falciparum in Lambaréné, Gabon | Q38909281 | ||
| Reassessment of the resistance of Plasmodium falciparum to chloroquine in Gabon: implications for the validity of tests in vitro vs. in vivo | Q38915533 | ||
| History and perspectives of medical research at the Albert Schweitzer Hospital in Lambaréné, Gabon | Q39381315 | ||
| In vitro activity of quinolines against Plasmodium falciparum in Gabon | Q39381323 | ||
| Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast | Q40364233 | ||
| Malaria epidemiology in the province of Moyen Ogoov, Gabon. | Q43329403 | ||
| Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial | Q43972330 | ||
| Plasmodium falciparum transmission intensity and infection rates in children in Gabon | Q44146182 | ||
| Artemether-lumefantrine for the treatment of Plasmodium malariae, Plasmodium ovale, and mixed Plasmodium malaria: A prospective clinical trial assessing species-specific efficacy in Gabon | Q47556680 | ||
| Efficacy of artesunate-amodiaquine, dihydroartemisinin-piperaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger | Q48023355 | ||
| P433 | issue | 1 | |
| P921 | main subject | malaria | Q12156 |
| Plasmodium falciparum | Q311383 | ||
| lumefantrine | Q904464 | ||
| Plasmodium falciparum malaria | Q18554672 | ||
| P304 | page(s) | 424 | |
| P577 | publication date | 2019-12-16 | |
| P1433 | published in | Malaria Journal | Q15749954 |
| P1476 | title | Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial | |
| P478 | volume | 18 |
Search more.